DeBose-Scarlett Evon, Ressler Andrew K, Friday Cassi, Prickett Kara K, Roberts James W, Gossage James R, Marchuk Douglas A
Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA.
Cure HHT, Monkton, Maryland, USA.
J Med Genet. 2025 Mar 20;62(4):281-288. doi: 10.1136/jmg-2024-110569.
Hereditary haemorrhagic telangiectasia (HHT) is an inherited disorder of vascular malformations. It is caused by inherited loss-of-function mutations in one of three genes, , or . We recently showed that HHT-associated vascular malformations from liver, lung, brain and skin develop via a two-hit genetic mechanism resulting from biallelic loss-of-function mutations in either or . Second-hit somatic mutations in have not been reported in HHT-associated vascular malformations. Here, we investigate a large, aggressively growing craniofacial arteriovenous malformation (AVM) from an individual with juvenile polyposis-HHT caused by a germline mutation in .
We sequenced DNA from the AVM using a targeted gene sequencing panel to at least 1000X to identify somatic mutations that might contribute to the development of the AVM. We analysed whole genome SNP genotyping data using the algorithm Mosaic Chromosomal Alterations (MoChA) to identify somatic loss of heterozygosity.
We confirmed the germline mutation in (c.1610A>T, p.Asp537Val) and identified a second-hit somatic mutation also in (c.350dup, p.Tyr117*) that occurred in relative to the germline mutation. We also identified somatic loss of heterozygosity on the q arm of chromosome 18, including . Additionally, we confirmed that the loss of heterozygosity causes loss of the wild-type allele. Thus, we identified two independent somatic alterations in causing biallelic loss of function in the AVM tissue.
We identified biallelic loss of function of in a craniofacial AVM, evidence that also follows the two-hit mutation mechanism of HHT-associated vascular malformation pathogenesis.
遗传性出血性毛细血管扩张症(HHT)是一种遗传性血管畸形疾病。它由三个基因之一、或的功能丧失性突变遗传所致。我们最近发现,肝脏、肺、脑和皮肤中与HHT相关的血管畸形是通过双打击遗传机制发展而来的,该机制由或的双等位基因功能丧失性突变引起。在与HHT相关的血管畸形中,尚未有关于的第二次打击体细胞突变的报道。在此,我们研究了一名因种系突变导致青少年息肉病 - HHT患者的一个大型、生长迅速的颅面动静脉畸形(AVM)。
我们使用靶向基因测序panel对AVM的DNA进行测序,深度至少达到1000X,以鉴定可能有助于AVM发展的体细胞突变。我们使用镶嵌染色体改变(MoChA)算法分析全基因组SNP基因分型数据,以鉴定体细胞杂合性缺失。
我们确认了中的种系突变(c.1610A>T,p.Asp537Val),并在中也鉴定出了第二个打击体细胞突变(c.350dup,p.Tyr117*),该突变相对于种系突变发生在中。我们还在18号染色体的q臂上鉴定出体细胞杂合性缺失,包括。此外,我们证实杂合性缺失导致野生型等位基因丢失。因此,我们在AVM组织中鉴定出导致双等位基因功能丧失的两个独立体细胞改变。
我们在颅面AVM中鉴定出双等位基因功能丧失,这证明也遵循与HHT相关的血管畸形发病机制的双打击突变机制。